Document is current
Any future updates will be listed below
-
Authors
Al-Dalakta, Astefanos
Tabaja, Chadi
Motairek, Issam
El Hajjar, Abdel Hadi
Agarwal, Neel
St. John, Julie
Laffin, Luke J.
- License Information
-
More Information
Article History
Accepted: 28 July 2024
First Online: 14 August 2024
Declarations
:
: Luke J. Laffin reports personal fees from Medtronic, Recor, Lilly, Idorsia, and Crispr Therapeutics; grants from Mineralys and AstraZeneca; and stock options from LucidAct Health, outside the submitted work. The other authors declare that they have no conflict of interest.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
